Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Obesity × Omeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Head and Neck Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Breast Neoplasms 2 Zollinger-Ellison Syndrome 1 Uterine Cervical Dysplasia 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Obesity 1 Mouth Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Inflammation 1 Gastrinoma 1 Colorectal Neoplasms 1 Chemotherapy Effect 1 Burkitt Lymphoma 1

Interventions

Vitamin D 2 Tirzepatide 2 licogliflozin 1 indole-3-carbinol 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Tablets 1 Specimen Handling 1 Resistance Training 1 Progestins 1 Pregabalin 1 Orlistat 1 Organizational Objectives 1 Omeprazole 1 Observation 1 Naltrexone 1 Metformin 1 Ketorolac 1 Exergaming 1 Exercise 1 Exenatide 1 Diet, Plant-Based 1 Dexmedetomidine 1 Dalteparin 1 Counseling 1 Cholecalciferol 1 Calcium Citrate 1 Calcium Carbonate 1 Calcitriol 1 CKD732 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡